| Date Announced: |
January 15, 2019 |
| Date Closed: |
January 17, 2019 |
| Deal Value: |
$7 million |
| Client Name: |
Emerald Health Sciences Inc. and Emerald Health Therapeutics, Inc. |
Bennett Jones acted for both Emerald Health Sciences and Emerald Health Therapeutics, Inc. in the secondary offering by EHS of 2.8 million shares of EHT to a single institutional investor at a price of $2.50 per Secondary Share for gross proceeds of $7 million. To facilitate the Secondary Offering, EHT filed a prospectus supplement in all of the provinces of Canada, except Quebec.
![Background Image]( style="background: url('/-/media/Images/BennettJones/Home/bennettjones_pattern_web_banner_background_v1_blue_charcoal.ashx'); background-size: cover; background-repeat: no-repeat;")
